Cargando…
Identification of Neoantigens in Two Murine Gastric Cancer Cell Lines Leading to the Neoantigen-Based Immunotherapy
SIMPLE SUMMARY: Despite the success of immune checkpoint inhibitors (ICI) for treating a variety of solid cancers, most gastric cancer patients are resistant to ICI monotherapies. Combinations of ICI with other therapies may be able to overcome this resistance. In order to develop combination immuno...
Autores principales: | Nagaoka, Koji, Sun, Changbo, Kobayashi, Yukari, Kanaseki, Takayuki, Tokita, Serina, Komatsu, Toshihiro, Maejima, Kazuhiro, Futami, Junichiro, Nomura, Sachiyo, Udaka, Keiko, Nakagawa, Hidewaki, Torigoe, Toshihiko, Kakimi, Kazuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750027/ https://www.ncbi.nlm.nih.gov/pubmed/35008270 http://dx.doi.org/10.3390/cancers14010106 |
Ejemplares similares
-
Neoantigen Dendritic Cell Vaccination Combined with Anti-CD38 and CpG Elicits Anti-Tumor Immunity against the Immune Checkpoint Therapy-Resistant Murine Lung Cancer Cell Line LLC1
por: Sun, Changbo, et al.
Publicado: (2021) -
Characterization of CD8(+) T-cell responses to non-anchor-type HLA class I neoantigens with single amino-acid substitutions
por: Shinkawa, Tomoyo, et al.
Publicado: (2021) -
Deep immunophenotyping at the single-cell level identifies a combination of anti-IL-17 and checkpoint blockade as an effective treatment in a preclinical model of data-guided personalized immunotherapy
por: Nagaoka, Koji, et al.
Publicado: (2020) -
Proteogenomic identification of an immunogenic HLA class I neoantigen in mismatch repair–deficient colorectal cancer tissue
por: Hirama, Tomomi, et al.
Publicado: (2021) -
Prediction and prioritization of neoantigens: integration of RNA sequencing data with whole‐exome sequencing
por: Karasaki, Takahiro, et al.
Publicado: (2017)